HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Neonatal pseudomonas infection — Clinical Guidelines

Overview

Neonatal Pseudomonas infections are serious bacterial infections primarily affecting premature or immunocompromised neonates, often linked to contaminated equipment or environments within neonatal intensive care units (NICUs). 12

Diagnosis

Clinical Presentation: Symptoms may include sepsis, pneumonia, or localized infections like conjunctivitis or wound infections. 12

Laboratory Tests: Blood cultures are crucial for confirming Pseudomonas aeruginosa infection. 12

Imaging: Chest X-rays may show signs of pneumonia; other imaging as indicated by clinical presentation. 12

Environmental Assessment: Consider equipment and environmental contamination, especially in NICUs. 12

Management

Antibiotics: Initial empirical therapy often includes broad-spectrum antibiotics, followed by targeted therapy based on culture and sensitivity results. Commonly used agents include ceftazidime or meropenem. 12

Supportive Care: Includes mechanical ventilation, fluid management, and treatment of organ dysfunction. 12

Equipment Decontamination: Rigorous cleaning and disinfection protocols for medical equipment to prevent nosocomial spread. 12

Special Populations

Premature Infants: Extremely vulnerable due to immature immune systems; infections can be rapidly progressive and severe. 12

NICU Patients: Higher risk due to prolonged hospital stays and exposure to contaminated equipment. 12

Key Recommendations

Implement stringent decontamination protocols for all medical equipment used in neonatal care to prevent Pseudomonas infections. (Evidence: Expert opinion 12)

Initiate broad-spectrum antibiotic therapy empirically in suspected neonatal Pseudomonas infections, adjusting based on culture and sensitivity results. (Evidence: Expert opinion 12)

Enhance surveillance and rapid response to suspected outbreaks in NICUs to contain transmission effectively. (Evidence: Expert opinion 12)

References

1 Feeney SA, Crilly MC, Christie S, Lewis J, McColgan AE, Niebel M et al.. Coxsackievirus B4 (CV-B4) linked to four severe neonatal infections including one fatal, Northern Ireland, October 2024 to February 2025. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2025. link 2 Sherlock LG, Krebs NF. Small and Mighty: Micronutrients at the Intersection of Neonatal Immunity and Infection. NeoReviews 2023. link 3 . Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion Summary, Number 797. Obstetrics and gynecology 2020. link 4 . Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797. Obstetrics and gynecology 2020. link 5 Sammons JS, Graf EH, Townsend S, Hoegg CL, Smathers SA, Coffin SE et al.. Outbreak of Adenovirus in a Neonatal Intensive Care Unit: Critical Importance of Equipment Cleaning During Inpatient Ophthalmologic Examinations. Ophthalmology 2019. link 6 Money D, Allen VM. No. 298-The Prevention of Early-Onset Neonatal Group B Streptococcal Disease. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2018. link 7 Silva JM, Stein AT, Schünemann HJ, Bordin R, Kuchenbecker R, de Lourdes Drachler M. Academic detailing and adherence to guidelines for Group B streptococci prenatal screening: a randomized controlled trial. BMC pregnancy and childbirth 2013. link 8 Langan EA, Agarwal RP, Subudhi CP, Judge MR. Aspergillus fumigatus: a potentially lethal ubiquitous fungus in extremely low birthweight neonates. Pediatric dermatology 2010. link 9 McCaffree MA, Riley HD. Pneumococcal septicemia and pneumonia in the neonatal period. The Journal of the Oklahoma State Medical Association 1993. link 10 Smyth RL, Bamford MF. Neonatal listeriosis: experience in Suffolk. The Journal of infection 1988. link92380-8) 11 Bergqvist G, Trovik M. Neonatal infections with Streptococcus pneumoniae. Scandinavian journal of infectious diseases 1985. link 12 Cumpston P, Narasimhan S. Pseudomonas infection and the anaesthetist. Anaesthesia and intensive care 1979. link 13 Miler JM, Spilsbury JF, Jones RJ, Roe EA, Lowbury EJ. A new polyvalent Pseudomonas vaccine. Journal of medical microbiology 1977. link

Neonatal pseudomonas infection